Oral, but not transdermal, administration of estrogens lowers tissue-type plasminogen activator levels without affecting its endothelial synthesis - Giltay, EJ; Gooren, LJG; Emeis, J; Kooistra, T; Stehouwer, CDA (Arterioscler Thromb Vase Biol, 2000)